EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer’s Disease: From Acute Neuronal Injury to Chronic Neurodegeneration

Stephan Neuschmid, Carla Schallerer, Barbara E Ehrlich iD, Declan McGuone iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189245 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Stephan Neuschmid und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Alzheimer Disease, Calcium Signaling, Neurons. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 285 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss of calcium homeostasis, a shared feature of Alzheimer’s Disease (AD) and Traumatic Brain Injury (TBI), activates enzyme-dependent cascades that promote protein misfolding, degrade synaptic architecture, impair axonal transport, and lead to neuronal death. Epidemiological studies identify TBI as a major risk factor for AD, yet the mechanistic basis for this association remains incompletely understood. Evidence from human and experimental studies implicate calcium dysregulation as a central link, triggering interconnected kinase, phosphatase, and protease networks that drive AD hallmark pathology, including amyloid-β (Aβ) accumulation and tau hyperphosphorylation. The calcium-dependent protease calpain is a key node in this network, regulating downstream enzyme activity, and cleaving essential scaffolding and signaling proteins. Selective vulnerability of the hippocampus and white matter to calcium-mediated damage may underlie cognitive deficits common to both conditions. In preclinical TBI and AD models, pharmacological inhibition of calcium-dependent enzymes confers neuroprotection. Recognizing disrupted calcium signaling as an upstream driver of post-traumatic neurodegeneration may enable early interventions to reduce AD risk among TBI survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticAlzheimer DiseaseCalcium SignalingNeuronsHumansAnimalsCalciumAmyloid beta-PeptidesCalpain

Stichwörter der Autor:innen

axonal degenerationbeta-amyloidcalcium dysregulationcalpaincognitive impairmentpost-traumatic dementiaprotein misfoldingsynaptic dysfunctiontauwhite matter injury

Substanzen

CalciumAmyloid beta-PeptidesCalpain

Autor:innen und Institutionen

  • School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
  • Department of Pharmacology, Yale School of Medicine, New Haven, CT 06510, USA.
  • Department of Pathology, Yale School of Medicine, New Haven, CT 06510, USA.

ORCID-Profile: Barbara E Ehrlich, Declan McGuone

Zitieren

APA

Neuschmid, S., Schallerer, C., Ehrlich, B. E., & McGuone, D. (2025). Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer’s Disease: From Acute Neuronal Injury to Chronic Neurodegeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189245

Vancouver

Neuschmid S, Schallerer C, Ehrlich BE, McGuone D. Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer’s Disease: From Acute Neuronal Injury to Chronic Neurodegeneration. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189245

BibTeX
@article{Neuschmid2025,
  author = {Neuschmid, Stephan and Schallerer, Carla and Ehrlich, Barbara E and McGuone, Declan},
  title = {Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer’s Disease: From Acute Neuronal Injury to Chronic Neurodegeneration},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189245}
}
Kostenlos starten →